Special liver transplant for teens with end-stage liver disease
Part of Digestive system clinical trials.
This trial tests a new way to transplant livers in teenagers with severe liver disease who cannot get a standard living donor transplant. It aims to see if a special type of transplant (called SALT) can help them get the liver they need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 7 and 18 years old.
- Child has end-stage liver disease and cannot get a large enough liver from a standard living donor transplant.
- Child must be in good general health to tolerate surgery and follow-up care.
- Guardians and child (if over 14) must agree to participate and sign a consent form.
- Child must not have serious heart or lung disease, liver cancer, certain genetic metabolic diseases, HIV, or other conditions that make surgery too risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a two-step liver surgery approach for people with advanced (not fully removable) liver cancer or end-stage liver disease, using chemotherapy first when applicable. The goal is to see if this staged plan can better control disease and allow safer surgery.
This Phase 2 study tests whether transplanting donor liver cells near lymph nodes can improve outcomes in people with advanced cirrhosis from certain liver conditions. It may help your liver function by adding healthy liver cells, but eligibility is tightly based on your current liver status and other health factors.
This trial tests a treatment called SALT for people with cirrhosis from hepatitis B who have serious complications. It aims to see if SALT can help improve outcomes for those who may need a liver transplant.
This trial is testing a treatment called SALT for people with liver cirrhosis and a specific type of liver cancer (HCC) caused by hepatitis B. It aims to help patients whose tumors are limited in size and number.
This trial tests whether a liver transplant plus salt solution (a special preservation fluid) can help people with colorectal cancer that has spread to the liver but cannot be surgically removed. The goal is to see if this approach can stop cancer growth and improve survival.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new End Stage Liver DIsease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.